In addition to splice variants, it is likely that modifier genes and genetic background, which have been shown to modulate and prolong embryonic survival in Brca2-null mice [49], as well as possibly chance events, contribute to the emerging cancer phenotype. Here, BRCA2 is linked to cancer.